PARENTERAL NUTRITION ASSOCIATED CHOLESTASIS
Clinical trials for PARENTERAL NUTRITION ASSOCIATED CHOLESTASIS explained in plain language.
Never miss a new study
Get alerted when new PARENTERAL NUTRITION ASSOCIATED CHOLESTASIS trials appear
Sign up with your email to follow new studies for PARENTERAL NUTRITION ASSOCIATED CHOLESTASIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study checks if IV fat emulsion prevents nutrient shortages in Long-Term patients
Disease control Recruiting nowThis study looks at how safe SMOFlipid is for children and adults who need IV nutrition for 8 weeks or more. It checks if the treatment causes a lack of essential fats or liver problems. About 100 participants will be followed to see how their bodies respond.
Matched conditions: PARENTERAL NUTRITION ASSOCIATED CHOLESTASIS
Phase: PHASE4 • Sponsor: Fresenius Kabi • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Fish oil treatment tested for kids with liver damage from IV nutrition
Disease control Recruiting nowThis study is testing the safety of Omegaven, a fish oil-based fat emulsion, in 40 children under 18 who have developed liver problems (cholestasis) from long-term IV nutrition. The main goal is to see how many children develop essential fatty acid deficiency during at least 8 we…
Matched conditions: PARENTERAL NUTRITION ASSOCIATED CHOLESTASIS
Sponsor: Fresenius Kabi • Aim: Disease control
Last updated Jun 26, 2026 13:42 UTC